(Total Views: 532)
Posted On: 08/15/2022 4:52:13 PM
Post# of 154064
gilead trodelvy "surprise"?
after poor OS results reported at ASCO, all of the sudden good numbers?
after second interim analysis, trodelvy has significant results and
"Gilead said it submitted an sBLA to FDA for this new breast cancer indication, but it also said it won’t present the actual OS data from the second interim analysis until an unidentified upcoming medical conference."
https://endpts.com/gileads-trodelvy-scores-su...onference/
after poor OS results reported at ASCO, all of the sudden good numbers?
after second interim analysis, trodelvy has significant results and
"Gilead said it submitted an sBLA to FDA for this new breast cancer indication, but it also said it won’t present the actual OS data from the second interim analysis until an unidentified upcoming medical conference."
https://endpts.com/gileads-trodelvy-scores-su...onference/
(0)
(0)
